Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare, Inc. (NYSE:MOH ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President and CEO Mark Keim - CFO Conference Call Participants Stephen Baxter - Wells Fargo Andrew Mok - Barclays Josh Raskin - Nephron Research A.J. Rice - UBS Justin Lake - Wolfe Research John Stansel - JP Morgan Sarah James - Cantor Fitzgerald Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Lance Wilkes - Bernstein Michael Ha - Baird George Hill - Deutsche Bank Dave Windley - Jefferies Operator Good day and welcome to the Molina Healthcare First Quarter 2025 Earnings Conference Call.
MOH continues to expect 2025 premium revenues to be around $42 billion.
Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Molina (MOH) came out with quarterly earnings of $6.08 per share, beating the Zacks Consensus Estimate of $5.86 per share. This compares to earnings of $5.73 per share a year ago.
MOH's first-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Evaluate the expected performance of Molina (MOH) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare, Inc.'s stock has shown resilience, with an over 15% YTD gain, despite broader market challenges, reflecting steady growth and strong operational performance. The company has achieved significant revenue and earnings growth, with a clear strategy targeting $52-$55 billion in premium revenue by 2027. Molina's diversified business across Medicaid, Medicare, and marketplace segments, coupled with industry-leading medical care margins, positions MOH stock well against potential market volatility.
Molina (MOH) reported earnings 30 days ago. What's next for the stock?
MOH expects total membership to be at 5.9 million by 2025-end.
Molina Healthcare, Inc. (NYSE:MOH ) Q4 2024 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President and Chief Executive Officer Mark Keim - Senior Executive Vice President and Chief Financial Officer Conference Call Participants Andrew Mok - Barclays Stephen Baxter - Wells Fargo Josh Raskin - Nephron Research Sarah James - Cantor Fitzgerald Justin Lake - Wolfe Research A.J. Rice - UBS Adam Ron - Bank of America Christian Borgmeyer - TD Cowen Michael Hall - Baird Scott Fidel - Stephens Operator Good day and welcome to Molina Healthcare Fourth Quarter 2024 Earnings Conference Call.